Navellier & Associates’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Navellier & Associates's RGEN Position: Q3 2023 in Review
Navellier & Associates sold out of Repligen (RGEN) in Q3 2023, closing a stake of 3,562 shares — an estimated $504K sold.
Navellier & Associates first reported a position in RGEN in Q2 2019 and held it in 17 quarters. The position peaked at $4.4M in Q1 2021. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.
- Navellier & Associates reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
- Navellier & Associates sold 3,562 Repligen shares in Q3 2023, an estimated $504K.
- Navellier & Associates first reported a position in Repligen in Q2 2019 and held it in 17 quarters.
- Navellier & Associates's Repligen position peaked at $4.4M in Q1 2021.
- 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.
Based on Navellier & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.